Monoamine oxidase-A modulates apoptotic cell death induced by staurosporine in human neuroblastoma cells

被引:56
作者
Fitzgerald, Julia C.
Ufer, Christoph
De Girolamo, Luigi A.
Kuhn, Hartmut
Billett, E. Ellen
机构
[1] Nottingham Trent Univ, Sch Biomed & Nat Sci, Nottingham NG11 8NS, England
[2] Univ Med Berlin Charite, Inst Biochem, Berlin, Germany
关键词
apoptosis; caspase; monoamine oxidase-A; reactive oxygen species; SH-SY5Y; staurosporine;
D O I
10.1111/j.1471-4159.2007.04921.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Monoamine oxidases (MAOs) are mitochondrial enzymes which control the levels of neurotransmitters in the brain and dietary amines in peripheral tissues via oxidative deamination. MAO has also been implicated in cell signalling. In this study, we describe the MAO-A isoform as functional in apoptosis induced by staurosporine (STS) in human dopaminergic neuroblastoma cells (SH-SY5Y). Increased levels of MAO-A activity were induced by STS, accompanied by increased MAO-A protein and activation of the initiator of the intrinsic pathway, caspase 9, and the executioner caspase 3. MAO-A mRNA levels were unaffected by STS, suggesting that changes in MAO-A protein are due to post-transcriptional events. Two unrelated MAO-A inhibitors reduced caspase activation. STS treatment resulted in sustained activation of the mitogen-activated protein kinase pathway enzymes extracellular regulated kinase, c-jun terminal kinase and p38, and depletion of the anti-apoptotic protein Bcl-2. These changes were significantly reversed by MAO inhibition. Production of reactive oxygen species was increased following STS exposure, which was blocked by both MAO inhibition and the antioxidant N-acetylcysteine. Therefore our data provide evidence that MAO-A, through its production of reactive oxygen species as a by-product of its catalytic activity on the mitochondrial surface, is recruited by the cell to enhance apoptotic signalling.
引用
收藏
页码:2189 / 2199
页数:11
相关论文
共 43 条
[1]   Expanding insights of mitochondrial dysfunction in Parkinson's disease [J].
Abou-Sleiman, PM ;
Muqit, MMK ;
Wood, NW .
NATURE REVIEWS NEUROSCIENCE, 2006, 7 (03) :207-219
[2]   An anti-Parkinson's disease drug, N-propargyl-1(R)-aminoindan (rasagiline), enhances expression of anti-apoptotic Bcl-2 in human dopaminergic SH-SY5Y cells [J].
Akao, Y ;
Maruyama, W ;
Yi, H ;
Shamoto-Nagai, M ;
Youdim, MBH ;
Naoi, M .
NEUROSCIENCE LETTERS, 2002, 326 (02) :105-108
[3]   CDNA CLONING OF HUMAN-LIVER MONOAMINE OXIDASE-A AND OXIDASE-B - MOLECULAR-BASIS OF DIFFERENCES IN ENZYMATIC-PROPERTIES [J].
BACH, AWJ ;
LAN, NC ;
JOHNSON, DL ;
ABELL, CW ;
BEMBENEK, ME ;
KWAN, SW ;
SEEBURG, PH ;
SHIH, JC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (13) :4934-4938
[4]   Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: Implications for Parkinson's disease [J].
Berman, SB ;
Hastings, TG .
JOURNAL OF NEUROCHEMISTRY, 1999, 73 (03) :1127-1137
[5]  
Berry MD, 2000, J NEUROSCI RES, V60, P150, DOI 10.1002/(SICI)1097-4547(20000415)60:2<150::AID-JNR3>3.0.CO
[6]  
2-4
[7]   Monoamine oxidase (MAO) in human peripheral tissues [J].
Billett, EE .
NEUROTOXICOLOGY, 2004, 25 (1-2) :139-148
[8]  
BILLETT EE, 1986, BIOCHEM J, V235, P2157
[9]   Mitochondrial free radical generation, oxidative stress, and aging [J].
Cadenas, E ;
Davies, KJA .
FREE RADICAL BIOLOGY AND MEDICINE, 2000, 29 (3-4) :222-230
[10]  
CHURCH RJ, 1994, P R MICROSC SOC, V29, P243